CorsiersurVevey, Switzerland
Merck Serono is engaged in a €300 million expansion of its biologics manufacturing campus in Corsier-sur-Vevey, Switzerland. The expanded Merck Serono Biotech Center will support the production of therapeutics for colorectal and head and neck cancers as well as autoimmune and inflammatory diseases. The project will feature two dedicated production suites, each with a 120,000-liter bioreactor capacity. A logistics center and a wastewater treatment station will also be constructed. Production is expected to begin in 2012.
